Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
JPMorgan Active Bond ETF (NYSEARCA:JBND) Shares Purchased by Vienna Asset Management LLC
Vienna Asset Management LLC boosted its position in JPMorgan Active Bond ETF (NYSEARCA:JBND – Free Report) by 91.8% during the...
WESCAP Management Group Inc. Decreases Stock Holdings in Invesco S&P SmallCap Value with Momentum ETF (NYSEARCA:XSVM)
WESCAP Management Group Inc. cut its stake in Invesco S&P SmallCap Value with Momentum ETF (NYSEARCA:XSVM – Free Report) by...
JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI) Shares Sold by Vienna Asset Management LLC
Vienna Asset Management LLC decreased its position in shares of JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI – Free Report) by...
Wexford Capital LP Makes New Investment in Sanofi (NASDAQ:SNY)
Wexford Capital LP purchased a new stake in Sanofi (NASDAQ:SNY – Free Report) during the third quarter, HoldingsChannel.com reports. The...
Ciena (NYSE:CIEN) Price Target Raised to $84.00 at Citigroup
Ciena (NYSE:CIEN – Get Free Report) had its price objective lifted by equities research analysts at Citigroup from $68.00 to...
Tabor Asset Management LP Acquires Shares of 433 Booking Holdings Inc. (NASDAQ:BKNG)
Tabor Asset Management LP bought a new position in Booking Holdings Inc. (NASDAQ:BKNG – Free Report) in the third quarter,...